Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs

Epilepsy and Behavior

Volumn 71, Issue , 2017, Pages 165-173

  De Sarro, Giovambattista ^a   Russo, Emilio ^a   Citraro, Rita ^a   Meldrum, Brian S ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Animal models; Audiogenic seizures; Epilepsy; Epileptogenesis; Generalized seizure; Neurotransmitters

Indexed keywords

ADENOSINE; ANTICONVULSIVE AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; CONVULSANT AGENT; DIAZEPAM; ETHOSUXIMIDE; EXCITATORY AMINO ACID; FELBAMATE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LEVETIRACETAM; NIMODIPINE; OXCARBAZEPINE; PERAMPANEL; PHENOBARBITAL; PHENYTOIN; QUETIAPINE; RETIGABINE; RISPERIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; AUDIOGENIC REFLEX EPILEPSY; DBA 2 MOUSE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; EPILEPTOGENESIS; GENETICALLY EPILEPSY PRONE RAT; KINDLING; MOUSE; NEUROTRANSMISSION; NONHUMAN; RAT; REFLEX EPILEPSY; REVIEW; SEIZURE SUSCEPTIBILITY; ANIMAL; AUDITORY STIMULATION; DBA MOUSE; DISEASE MODEL; DRUG EFFECTS; GENETIC PREDISPOSITION; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSGENIC RAT;

ACOUSTIC STIMULATION; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; EPILEPSY, REFLEX; GENETIC PREDISPOSITION TO DISEASE; KINDLING, NEUROLOGIC; MICE; MICE, INBRED DBA; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC;

EID: 84939508263     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.06.030     Document Type: Review

References (163)

1. Meldrum, B.S., Neurotransmission in epilepsy. Epilepsia 36:Suppl. 1 (1995), S30–S35.
2. Sierra-Paredes, G., Sierra-Marcuno, G., Extrasynaptic GABA and glutamate receptors in epilepsy. CNS Neurol Disord Drug Targets 6 (2007), 288–300.
3. Noebels, J.L., Targeting epilepsy genes. Neuron 16 (1996), 241–244.
4. Berkovic, S.F., Scheffer, I.E., Genetics of the epilepsies. Epilepsia 42:Suppl. 5 (2001), 16–23.
5. Cooper, E.C., Jan, L.Y., Ion channel genes and human neurological disease: recent progress, prospects, and challenges. Proc Natl Acad Sci U S A 96 (1999), 4759–4766.
6. Loscher, W., Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20 (2011), 359–368.
7. Sarkisian, M.R., Overview of the current animal models for human seizure and epileptic disorders. Epilepsy Behav 2 (2001), 201–216.
8. Seyfried, T.N., Todorova, M.T., Poderycki, M.J., Experimental models of multifactorial epilepsies: the EL mouse and mice susceptible to audiogenic seizures. Adv Neurol 79 (1999), 279–290.
9. Menini, C., Silva-Barrat, C., The photosensitive epilepsy of the baboon. A model of generalized reflex epilepsy. Adv Neurol 75 (1998), 29–47.
10. Batini, C., Teillet, M.A., Naquet, R., An avian model of genetic reflex epilepsy. Arch Ital Biol 142 (2004), 297–312.
11. Ullal, G.R., Satishchandra, P., Shankar, S.K., Hyperthermic seizures: an animal model for hot-water epilepsy. Seizure 5 (1996), 221–228.
12. Neumann, P.E., Seyfried, T.N., Mapping of two genes that influence susceptibility to audiogenic seizures in crosses of C57BL/6J and DBA/2J mice. Behav Genet 20 (1990), 307–323.
13. Faingold, C.L., The genetically epilepsy-prone rat. Gen Pharmacol 19 (1988), 331–338.
14. Jobe, P.C., Dailey, J.W., Neurobiology of seizure predisposition in the genetically epilepsy prone rat. Proc West Pharmacol Soc 34 (1991), 223–225.
15. Seyfried, T.N., Audiogenic seizures in mice. Fed Proc 38 (1979), 2399–2404.
16. King, J.T. Jr., LaMotte, C.C., EL mouse as a model of focal epilepsy: a review. Epilepsia 30 (1989), 257–265.
17. Bertorelli, R., Adami, M., Ongini, E., The Mongolian gerbil in experimental epilepsy. Ital J Neurol Sci 16 (1995), 101–106.
18. Chapman, A.G., Croucher, M.J., Meldrum, B.S., Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneimittelforschung 34 (1984), 1261–1264.
19. Ross, K.C., Coleman, J.R., Developmental and genetic audiogenic seizure models: behavior and biological substrates. Neurosci Biobehav Rev 24 (2000), 639–653.
20. Seyfried, T.N., Yu, R.K., Glaser, G.H., Genetic analysis of audiogenic seizure susceptibility in C57BL/6J X DBA/2J recombinant inbred strains of mice. Genetics 94 (1980), 701–718.
21. Schreiber, R.A., Graham, J.M. Jr., Audiogenic priming in DBA/2J and C57BL/6J mice: interactions among age, prime-to-test interval and index of seizure. Dev Psychobiol 9 (1976), 57–66.
22. Jobe, P.C., Laird, H.E., Neurotransmitter abnormalities as determinants of seizure susceptibility and intensity in the genetic models of epilepsy. Biochem Pharmacol 30 (1981), 3137–3144.
23. Kellogg, C., Audiogenic seizures: relation to age and mechanisms of monoamine neurotransmission. Brain Res 106 (1976), 87–103.
24. De Sarro, G., Di Paola, E.D., Ferreri, G., De Sarro, A., Fischer, W., Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur J Pharmacol 442 (2002), 205–213.
25. De Sarro, G., Chimirri, A., Meldrum, B.S., Group III mGlu receptor agonists potentiate the anticonvulsant effect of AMPA and NMDA receptor block. Eur J Pharmacol 451 (2002), 55–61.
26. De Sarro, G., Gareri, P., Falconi, U., De Sarro, A., 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur J Pharmacol 394 (2000), 275–288.
27. De Sarro, G., Gratteri, S., Bonacci, F., Musumeci, S.A., Elia, M., De Sarro, A., Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur J Pharmacol 388 (2000), 163–170.
28. De Sarro, G., Gratteri, S., Naccari, F., Pasculli, M.P., De Sarro, A., Influence of D-cycloserine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice. Epilepsy Res 40 (2000), 109–121.
29. De Sarro, G., Rotiroti, D., Audino, M.G., Gratteri, S., Nistico, G., Effects of interleukin-2 on various models of experimental epilepsy in DBA/2 mice. Neuroimmunomodulation 1 (1994), 361–369.
30. De Sarro, G., Ascioti, C., di Paola, E.D., Vidal, M.J., De Sarro, A., Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L calcium channel in DBA/2 mice. Gen Pharmacol 23 (1992), 1205–1216.
31. De Sarro, G., Meldrum, B.S., De Sarro, A., Patel, S., Excitatory neurotransmitters in the lateral habenula and pedunculopontine nucleus of rat modulate limbic seizures induced by pilocarpine. Brain Res 591 (1992), 209–222.
32. Tunnicliff, G., Wimer, C.C., Wimer, R.E., Relationships between neurotransmitter metabolism and behaviour in seven inbred strains of mice. Brain Res 61 (1973), 428–434.
33. Seyfried, T.N., Glaser, G.H., Yu, R.K., Thyroid hormone influence on the susceptibility of mice to audiogenic seizures. Science 205 (1979), 598–600.
34. Schreiber, R.A., Developmental changes in brain glucose, glycogen, phosphocreatine, and ATP levels in DBA/2J and C57BL/6J mice, and audiogenic seizures. J Neurochem 37 (1981), 655–661.
35. Hertz, L., Schousboe, A., Formby, B., Lennox-Buchthal, M., Some age-dependent biochemical changes in mice susceptible to seizures. Epilepsia 15 (1974), 619–631.
36. Reichert, W.H., Cerebral magnesium and sodium–potassium ATPase following audiogenic seizures in mice. Exp Neurol 49 (1975), 596–600.
37. Horton, R., Anlezark, G., Meldrum, B., Noradrenergic influences on sound-induced seizures. J Pharmacol Exp Ther 214 (1980), 437–442.
38. Jazrawi, S.P., Horton, R.W., Brain adrenoceptor binding sites in mice susceptible (DBA/2J) and resistant (C57 Bl/6) to audiogenic seizures. J Neurochem 47 (1986), 173–177.
39. Uteshev, V.V., Tupal, S., Mhaskar, Y., Faingold, C.L., Abnormal serotonin receptor expression in DBA/2 mice associated with susceptibility to sudden death due to respiratory arrest. Epilepsy Res 88 (2010), 183–188.
40. Lippiello, P., Hoxha, E., Volpicelli, F., Lo Duca, G., Tempia, F., Miniaci, M.C., Noradrenergic modulation of the parallel fiber-Purkinje cell synapse in mouse cerebellum. Neuropharmacology 89 (2015), 33–42.
41. Croucher, M.J., Collins, J.F., Meldrum, B.S., Anticonvulsant action of excitatory amino acid antagonists. Science 216 (1982), 899–901.
42. Chapman, A.G., Woodburn, V.L., Woodruff, G.N., Meldrum, B.S., Anticonvulsant effect of reduced NMDA receptor expression in audiogenic DBA/2 mice. Epilepsy Res 26 (1996), 25–35.
43. De Sarro, G., Ferreri, G., Gareri, P., Russo, E., De Sarro, A., Gitto, R., et al. Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents. Pharmacol Biochem Behav 74 (2003), 595–602.
44. Ferreri, G., Chimirri, A., Russo, E., Gitto, R., Gareri, P., De Sarro, A., et al. Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents. Pharmacol Biochem Behav 77 (2004), 85–94.
45. Russo, E., Constanti, A., Ferreri, G., Citraro, R., De Sarro, G., Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 46 (2004), 865–878.
46. Gitto, R., Caruso, R., Orlando, V., Quartarone, S., Barreca, M.L., Ferreri, G., et al. Synthesis and anticonvulsant properties of tetrahydroisoquinoline derivatives. Farmaco 59 (2004), 7–12.
47. Quartarone, S., Caruso, R., Orlando, V., Russo, E., De Sarro, G., Chimirri, A., Synthesis and anticonvulsant activity of N-3 substituted 2,3-benzodiazepines. Farmaco 59 (2004), 353–358.
48. Moldrich, R.X., Chapman, A.G., De Sarro, G., Meldrum, B.S., Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol 476 (2003), 3–16.
49. Chapman, A.G., Graham, J.L., Patel, S., Meldrum, B.S., Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio. Epilepsia 32 (1991), 578–587.
50. Smith, S.E., Durmuller, N., Meldrum, B.S., The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol 201 (1991), 179–183.
51. Meldrum, B.S., Craggs, M.D., Durmuller, N., Smith, S.E., Chapman, A.G., The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates. Epilepsy Res Suppl 9 (1992), 307–311.
52. De Sarro, G., Ammendola, D., Nava, F., De Sarro, A., Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice. Brain Res 671 (1995), 131–140.
53. De Sarro, G., Gitto, R., Rizzo, M., Zappia, M., De Sarro, A., 1,4-Benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice. Gen Pharmacol 27 (1996), 935–941.
54. De Sarro, G., Ongini, E., Bertorelli, R., Aguglia, U., De Sarro, A., Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice. Pharmacol Biochem Behav 55 (1996), 281–287.
55. De Sarro, G., Trimarchi, G.R., Sinopoli, S., Masuda, Y., De Sarro, A., Anticonvulsant effects of U-54494A and U-50488H in genetically epilepsy-prone rats and DBA/2 mice: a possible involvement of glycine/NMDA receptor complex. Gen Pharmacol 24 (1993), 439–447.
56. De Luca, L., Gitto, R., Barreca, M.L., Caruso, R., Quartarone, S., Citraro, R., et al. 3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents. Arch Pharm (Weinheim) 339 (2006), 388–400.
57. Inyushin, M., Kucheryavykh, L.Y., Kucheryavykh, Y.V., Nichols, C.G., Buono, R.J., Ferraro, T.N., et al. Potassium channel activity and glutamate uptake are impaired in astrocytes of seizure-susceptible DBA/2 mice. Epilepsia 51 (2010), 1707–1713.
58. Sykes, C.C., Horton, R.W., Cerebral glutamic acid decarboxylase activity and gamma-aminobutyric acid concentrations in mice susceptible or resistant to audiogenic seizures. J Neurochem 39 (1982), 1489–1491.
59. Horton, R.W., Prestwich, S.A., Meldrum, B.S., gamma-Aminobutyric acid and benzodiazepine binding sites in audiogenic seizure-susceptible mice. J Neurochem 39 (1982), 864–870.
60. Robertson, H.A., Audiogenic seizures: increased benzodiazepine receptor binding in a susceptible strain of mice. Eur J Pharmacol 66 (1980), 249–252.
61. De Sarro, G., Chimirri, A., Zappala, M., Guisti, P., Lipartiti, M., De Sarro, A., Azirino[1, 2-d][1, 4]benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice. Gen Pharmacol 27 (1996), 1155–1162.
62. De Sarro, G., Chimirri, A., McKernan, R., Quirk, K., Giusti, P., De Sarro, A., Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice. Pharmacol Biochem Behav 58 (1997), 281–289.
63. De Sarro, G., Carotti, A., Campagna, F., McKernan, R., Rizzo, M., Falconi, U., et al. Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3-b]indol-3(3H)-ones in mice. Pharmacol Biochem Behav 65 (2000), 475–487.
64. Dragunow, M., Goddard, G.V., Laverty, R., Is adenosine an endogenous anticonvulsant?. Epilepsia 26 (1985), 480–487.
65. Von Lubitz, D.K., Paul, I.A., Carter, M., Jacobson, K.A., Effects of N6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice. Eur J Pharmacol 249 (1993), 265–270.
66. Zhang, G., Franklin, P.H., Murray, T.F., Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J Pharmacol Exp Ther 264 (1993), 1415–1424.
67. De Sarro, G., De Sarro, A., Di Paola, E.D., Bertorelli, R., Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur J Pharmacol 371 (1999), 137–145.
68. De Sarro, G., Russo, E., Ferreri, G., Giuseppe, B., Flocco, M.A., Di Paola, E.D., et al. Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice. Pharmacol Biochem Behav 77 (2004), 761–766.
69. De Sarro, G., Ibbadu, G.F., Marra, R., Rotiroti, D., Loiacono, A., Donato Di Paola, E., et al. Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice. Neurosci Res 50 (2004), 37–44.
70. De Sarro, A., Naccari, F., Imperatore, C., De Sarro, G.B., Comparative epileptogenic properties of two monobactam derivatives in C57, Swiss and DBA/2 mice. J Antimicrob Chemother 38 (1996), 475–484.
71. De Sarro, A., Zappala, M., Chimirri, A., Grasso, S., De Sarro, G.B., Quinolones potentiate cefazolin-induced seizures in DBA/2 mice. Antimicrob Agents Chemother 37 (1993), 1497–1503.
72. De Sarro, A., Ammendola, D., Zappala, M., Grasso, S., De Sarro, G.B., Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats. Antimicrob Agents Chemother 39 (1995), 232–237.
73. Russo, E., Donato di Paola, E., Gareri, P., Siniscalchi, A., Labate, A., Gallelli, L., et al. Pharmacodynamic potentiation of antiepileptic drugs’ effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol Res 70 (2013), 1–12.
74. De Sarro, G., Paola, E.D., Gratteri, S., Gareri, P., Rispoli, V., Siniscalchi, A., et al. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Pharmacol Res 65 (2012), 285–296.
75. Fischer, W., Kittner, H., Regenthal, R., Russo, E., De Sarro, G., Effects of piracetam alone and in combination with antiepileptic drugs in rodent seizure models. J Neural Transm 111 (2004), 1121–1139.
76. De Sarro, G., Siniscalchi, A., Ferreri, G., Gallelli, L., De Sarro, A., NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice. Eur J Pharmacol 408 (2000), 25–34.
77. De Sarro, G.B., De Sarro, A., Antagonists of adenosine and alpha-2-adrenoceptors reverse the anticonvulsant effects of tizanidine in DBA/2 mice. Neuropharmacology 28 (1989), 211–215.
78. De Sarro, G., Nava, F., Aguglia, U., De Sarro, A., Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Neuropharmacology 35 (1996), 153–158.
79. De Sarro, G., Spagnolo, C., Gareri, P., Gallelli, L., De Sarro, A., Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice. Eur J Pharmacol 349 (1998), 179–185.
80. De Sarro, G., Di Paola, E.D., Conte, G., Pasculli, M.P., De Sarro, A., Influence of retigabine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice. Naunyn Schmiedebergs Arch Pharmacol 363 (2001), 330–336.
81. Donato Di Paola, E., Gareri, P., Davoli, A., Gratteri, S., Scicchitano, F., Naccari, C., et al. Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Epilepsy Res 75 (2007), 112–121.
82. Gareri, P., Condorelli, D., Belluardo, N., Gratteri, S., Ferreri, G., Donato Di Paola, E., et al. Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur J Pharmacol 484 (2004), 49–56.
83. Reigel, C.E., Jobe, P.C., Dailey, J.W., Savage, D.D., Ontogeny of sound-induced seizures in the genetically epilepsy-prone rat. Epilepsy Res 4 (1989), 63–71.
84. Dailey, J.W., Reigel, C.E., Mishra, P.K., Jobe, P.C., Neurobiology of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res 3 (1989), 3–17.
85. Coffey, L.L., Reith, M.E., Chen, N.H., Mishra, P.K., Jobe, P.C., Amygdala kindling of forebrain seizures and the occurrence of brainstem seizures in genetically epilepsy-prone rats. Epilepsia 37 (1996), 188–197.
86. Kurtz, B.S., Lehman, J., Garlick, P., Amberg, J., Mishra, P.K., Dailey, J.W., et al. Penetrance and expressivity of genes involved in the development of epilepsy in the genetically epilepsy-prone rat (GEPR). J Neurogenet 15 (2001), 233–244.
87. Mishra, P.K., Dailey, J.W., Reigel, C.E., Tomsic, M.L., Jobe, P.C., Sex-specific distinctions in audiogenic convulsions exhibited by severe seizure genetically epilepsy-prone rats (GEPR-9s). Epilepsy Res 2 (1988), 309–316.
88. Mishra, P.K., Dailey, J.W., Reigel, C.E., Jobe, P.C., Audiogenic convulsions in moderate seizure genetically epilepsy-prone rats (GEPR-3s). Epilepsy Res 3 (1989), 191–198.
89. Faingold, C.L., Neuronal networks in the genetically epilepsy-prone rat. Adv Neurol 79 (1999), 311–321.
90. Jobe, P.C., Mishra, P.K., Adams-Curtis, L.E., Deoskar, V.U., Ko, K.H., Browning, R.A., et al. The genetically epilepsy-prone rat (GEPR). Ital J Neurol Sci 16 (1995), 91–99.
91. Consroe, P., Picchioni, A., Chin, L., Audiogenic seizure susceptible rats. Fed Proc 38 (1979), 2411–2416.
92. Faingold, C.L., Gehlbach, G., Caspary, D.M., Decreased effectiveness of GABA-mediated inhibition in the inferior colliculus of the genetically epilepsy-prone rat. Exp Neurol 93 (1986), 145–159.
93. Evans, M.S., Cady, C.J., Disney, K.E., Yang, L., Laguardia, J.J., Three brief epileptic seizures reduce inhibitory synaptic currents, GABA(A) currents, and GABA(A)-receptor subunits. Epilepsia 47 (2006), 1655–1664.
94. Meldrum, B., Millan, M., Patel, S., de Sarro, G., Anti-epileptic effects of focal micro-injection of excitatory amino acid antagonists. J Neural Transm 72 (1988), 191–200.
95. De Sarro, A., Trimarchi, G.R., Ammendola, D., De Sarro, G., Repeated treatment with quinolones potentiates the seizures induced by aminophylline in genetically epilepsy-prone rats. Gen Pharmacol 23 (1992), 853–859.
96. De Sarro, A., Ammendola, D., Juliano, M., Gareri, P., De Sarro, G., Only some anticonvulsants protect against seizures induced by aminophylline in quinolone-treated genetically epilepsy prone rats. Gen Pharmacol 24 (1993), 1393–1401.
97. De Sarro, G., Di Paola, E.D., Gareri, P., Gallelli, L., Scotto, G., De Sarro, A., Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats. Eur J Pharmacol 368 (1999), 149–159.
98. De Sarro, G., De Sarro, A., Federico, F., Meldrum, B.S., Anticonvulsant properties of some calcium antagonists on sound-induced seizures in genetically epilepsy prone rats. Gen Pharmacol 21 (1990), 769–778.
99. Jobe, P.C., Mishra, P.K., Browning, R.A., Wang, C., Adams-Curtis, L.E., Ko, K.H., et al. Noradrenergic abnormalities in the genetically epilepsy-prone rat. Brain Res Bull 35 (1994), 493–504.
100. Dailey, J.W., Mishra, P.K., Ko, K.H., Penny, J.E., Jobe, P.C., Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Epilepsia 32 (1991), 168–173.
101. Jobe, P.C., Dailey, J.W., Reigel, C.E., Noradrenergic and serotonergic determinants of seizure susceptibility and severity in genetically epilepsy-prone rats. Life Sci 39 (1986), 775–782.
102. Dailey, J.W., Mishra, P.K., Ko, K.H., Penny, J.E., Jobe, P.C., Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci 50 (1992), 319–326.
103. Jobe, P.C., Laird, H.E. II, Ko, K.H., Ray, T., Dailey, J.W., Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy-prone rat. Epilepsia 23 (1982), 359–366.
104. Ryu, J.R., Jobe, P.C., Milbrandt, J.C., Mishra, P.K., Clough, R.W., Browning, R.A., et al. Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues. Exp Neurol 156 (1999), 84–91.
105. Faingold, C.L., Travis, M.A., Gehlbach, G., Hoffmann, W.E., Jobe, P.C., Laird, H.E. II, et al. Neuronal response abnormalities in the inferior colliculus of the genetically epilepsy-prone rat. Electroencephalogr Clin Neurophysiol 63 (1986), 296–305.
106. Jobe, P.C., Picchioni, A.L., Chin, L., Role of brain norepinephrine in audiogenic seizure in the rat. J Pharmacol Exp Ther 184 (1973), 1–10.
107. Dailey, J.W., Jobe, P.C., Anticonvulsant drugs and the genetically epilepsy-prone rat. Fed Proc 44 (1985), 2640–2644.
108. Jobe, P.C., Dailey, J.W., Genetically epilepsy-prone rats (GEPRs) in drug research. CNS Drug Rev 6 (2000), 241–260.
109. Hjeresen, D.L., Franck, J.E., Amend, D.L., Ontogeny of seizure incidence, latency, and severity in genetically epilepsy prone rats. Dev Psychobiol 20 (1987), 355–363.
110. Ribak, C.E., Roberts, R.C., Byun, M.Y., Kim, H.L., Anatomical and behavioral analyses of the inheritance of audiogenic seizures in the progeny of genetically epilepsy-prone and Sprague–Dawley rats. Epilepsy Res 2 (1988), 345–355.
111. Thompson, J.L., Carl, F.G., Holmes, G.L., Effects of age on seizure susceptibility in genetically epilepsy-prone rats (GEPR-9s). Epilepsia 32 (1991), 161–167.
112. Franck, J.E., Ginter, K.L., Schwartzkroin, P.A., Developing genetically epilepsy-prone rats have an abnormal seizure response to flurothyl. Epilepsia 30 (1989), 1–6.
113. Holmes, G.L., Thompson, J.L., Marchi, T.A., Gabriel, P.S., Hogan, M.A., Carl, F.G., et al. Effects of seizures on learning, memory, and behavior in the genetically epilepsy-prone rat. Ann Neurol 27 (1990), 24–32.
114. De Sarro, G., Di Paola, E.D., Aguglia, U., de Sarro, A., Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats. Pharmacol Biochem Behav 55 (1996), 39–48.
115. Faingold, C.L., Randall, M.E., Anderson, C.A., Blockade of GABA uptake with tiagabine inhibits audiogenic seizures and reduces neuronal firing in the inferior colliculus of the genetically epilepsy-prone rat. Exp Neurol 126 (1994), 225–232.
116. Dailey, J.W., Cheong, J.H., Ko, K.H., Adams-Curtis, L.E., Jobe, P.C., Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response. Neurosci Lett 195 (1995), 77–80.
117. Smith, S.E., al-Zubaidy, Z.A., Chapman, A.G., Meldrum, B.S., Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat. Epilepsy Res 15 (1993), 101–111.
118. Graumlich, J.F., McLaughlin, R.G., Birkhahn, D., Shah, N., Burk, A., Jobe, P.C., et al. Carbamazepine pharmacokinetics–pharmacodynamics in genetically epilepsy-prone rats. Eur J Pharmacol 369 (1999), 305–311.
119. Chapman, A.G., Yip, P.K., Yap, J.S., Quinn, L.P., Tang, E., Harris, J.R., et al. Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid). Eur J Pharmacol 368 (1999), 17–24.
120. Browning, R.A., Wood, A.V., Merrill, M.A., Dailey, J.W., Jobe, P.C., Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors. Eur J Pharmacol 336 (1997), 1–6.
121. De Sarro, G., De Sarro, A., Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats. Eur J Pharmacol 215 (1992), 221–229.
122. De Sarro, G.B., De Sarro, A., Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene. Neuropharmacology 32 (1993), 51–58.
123. De Sarro, G., Rizzo, M., Spagnolo, C., Gitto, R., De Sarro, A., Scotto, G., et al. Anticonvulsant activity and plasma level of 2,3-benzodiazepin-4-ones (CFMs) in genetically epilepsy-prone rats. Pharmacol Biochem Behav 63 (1999), 621–627.
124. De Sarro, G., Rizzo, M., Sinopoli, V.A., Gitto, R., De Sarro, A., Zappala, M., et al. Relationship between anticonvulsant activity and plasma level of some 2,3-benzodiazepines in genetically epilepsy-prone rats. Pharmacol Biochem Behav 61 (1998), 215–220.
125. Gareri, P., Condorelli, D., Belluardo, N., Russo, E., Loiacono, A., Barresi, V., et al. Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs). Neuropharmacology 47 (2004), 1205–1216.
126. N'Gouemo, P., Yasuda, R.P., Faingold, C.L., Protein expression of small conductance calcium-activated potassium channels is altered in inferior colliculus neurons of the genetically epilepsy-prone rat. Brain Res 1270 (2009), 107–111.
127. N'Gouemo, P., Yasuda, R., Faingold, C.L., Seizure susceptibility is associated with altered protein expression of voltage-gated calcium channel subunits in inferior colliculus neurons of the genetically epilepsy-prone rat. Brain Res 1308 (2010), 153–157.
128. Reigel, C.E., Dailey, J.W., Jobe, P.C., The genetically epilepsy-prone rat: an overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs. Life Sci 39 (1986), 763–774.
129. Yan, Q.S., Jobe, P.C., Dailey, J.W., Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats. Br J Pharmacol 115 (1995), 1314–1318.
130. Yan, Q.S., Jobe, P.C., Cheong, J.H., Ko, K.H., Dailey, J.W., Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Naunyn Schmiedebergs Arch Pharmacol 350 (1994), 149–152.
131. Statnick, M.A., Dailey, J.W., Jobe, P.C., Browning, R.A., Abnormalities in brain serotonin concentration, high-affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats. Epilepsia 37 (1996), 311–321.
132. Citraro, R., Scicchitano, F., De Fazio, S., Raggio, R., Mainardi, P., Perucca, E., et al. Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. Epilepsy Res 95 (2011), 60–69.
133. 2 +. Eur J Pharmacol 328 (1997), 153–162.
134. Yan, Q.S., Mishra, P.K., Burger, R.L., Bettendorf, A.F., Jobe, P.C., Dailey, J.W., Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J Pharmacol Exp Ther 261 (1992), 652–659.
135. Brennan, T.J., Seeley, W.W., Kilgard, M., Schreiner, C.E., Tecott, L.H., Sound-induced seizures in serotonin 5-HT2c receptor mutant mice. Nat Genet 16 (1997), 387–390.
136. Loscher, W., Czuczwar, S.J., Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy. Neurosci Lett 60 (1985), 201–206.
137. Jobe, P.C., Browning, R.A., The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav 7 (2005), 602–619.
138. Jobe, P.C., Shared mechanisms of antidepressant and antiepileptic treatments: drugs and devices. Clin EEG Neurosci 35 (2004), 25–37.
139. Jobe, P.C., Current and future therapeutic opportunities in the comorbidity between the epilepsies and affective disorders. Clin EEG Neurosci 35 (2004), 1–3.
140. Jobe, P.C., Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav 4:Suppl. 3 (2003), S14–S24.
141. Jobe, P.C., Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches. Clin EEG Neurosci 35 (2004), 53–68.
142. Kanner, A.M., Depression in epilepsy: a neurobiologic perspective. Epilepsy Curr 5 (2005), 21–27.
143. Jobe, P.C., Dailey, J.W., Wernicke, J.F., A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol 13 (1999), 317–356.
144. De Sarro, A., De Sarro, G.B., Responsiveness of genetically epilepsy-prone rats to aminophylline-induced seizures and interactions with quinolones. Neuropharmacology 30 (1991), 169–176.
145. De Sarro, A., Grasso, S., Zappala, M., Nava, F., De Sarro, G., Convulsant effects of some xanthine derivatives in genetically epilepsy-prone rats. Naunyn Schmiedebergs Arch Pharmacol 356 (1997), 48–55.
146. Browning, R.A., Wang, C., Lanker, M.L., Jobe, P.C., Electroshock- and pentylenetetrazol-induced seizures in genetically epilepsy-prone rats (GEPRs): differences in threshold and pattern. Epilepsy Res 6 (1990), 1–11.
147. Millan, M.H., Wardley-Smith, B., Durmuller, N., Meldrum, B.S., The high pressure neurological syndrome in genetically epilepsy prone rats: protective effect of 2-amino-7-phosphono heptanoate. Exp Neurol 112 (1991), 317–320.
148. Bourn, W.M., Garrett, R.L., Increased susceptibility of audiogenic rats to barbital withdrawal convulsions. Pharmacol Biochem Behav 19 (1983), 839–841.
149. Citraro, R., Leo, A., Aiello, R., Pugliese, M., Russo, E., De Sarro, G., Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats. Neurotherapeutics 12 (2015), 250–262.
150. Savage, D.D., Reigel, C.E., Jobe, P.C., The development of kindled seizures is accelerated in the genetically epilepsy-prone rat. Life Sci 39 (1986), 879–886.
151. Marescaux, C., Vergnes, M., Kiesmann, M., Depaulis, A., Micheletti, G., Warter, J.M., Kindling of audiogenic seizures in Wistar rats: an EEG study. Exp Neurol 97 (1987), 160–168.
152. Garcia-Cairasco, N., Wakamatsu, H., Oliveira, J.A., Gomes, E.L., Del Bel, E.A., Mello, L.E., Neuroethological and morphological (Neo-Timm staining) correlates of limbic recruitment during the development of audiogenic kindling in seizure susceptible Wistar rats. Epilepsy Res 26 (1996), 177–192.
153. Hirsch, E., Maton, B., Vergnes, M., Depaulis, A., Marescaux, C., Reciprocal positive transfer between kindling of audiogenic seizures and electrical kindling of inferior colliculus. Epilepsy Res 15 (1993), 133–139.
154. De Sarro, G., De Sarro, A., Ammendola, D., Patel, S., Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats. Brain Res 734 (1996), 91–97.
155. Pitkanen, A., Therapeutic approaches to epileptogenesis—hope on the horizon. Epilepsia 51:Suppl. 3 (2010), 2–17.
156. Naritoku, D.K., Mecozzi, L.B., Aiello, M.T., Faingold, C.L., Repetition of audiogenic seizures in genetically epilepsy-prone rats induces cortical epileptiform activity and additional seizure behaviors. Exp Neurol 115 (1992), 317–324.
157. Merrill, M.A., Clough, R.W., Jobe, P.C., Browning, R.A., Brainstem seizure severity regulates forebrain seizure expression in the audiogenic kindling model. Epilepsia 46 (2005), 1380–1388.
158. White, H.S., Loscher, W., Searching for the ideal antiepileptogenic agent in experimental models: single treatment versus combinatorial treatment strategies. Neurotherapeutics 11 (2014), 373–384.
159. Shin, E.J., Ko, K.H., Kim, W.K., Chae, J.S., Yen, T.P., Kim, H.J., et al. Role of glutathione peroxidase in the ontogeny of hippocampal oxidative stress and kainate seizure sensitivity in the genetically epilepsy-prone rats. Neurochem Int 52 (2008), 1134–1147.
160. Tupal, S., Faingold, C.L., The amygdala to periaqueductal gray pathway: plastic changes induced by audiogenic kindling and reversal by gabapentin. Brain Res 1475 (2012), 71–79.
161. Russo, E., Citraro, R., De Fazio, S., Torcasio, G., De Sarro, G., Di Paola, E.D., Effects of ethanol on the development of genetically determined epilepsies in rats. Int J Dev Neurosci 26 (2008), 739–744.
162. Fisher, R.S., Animal models of the epilepsies. Brain Res Brain Res Rev 14 (1989), 245–278.
163. Loscher, W., Meldrum, B.S., Evaluation of anticonvulsant drugs in genetic animal models of epilepsy. Fed Proc 43 (1984), 276–284.